Fas (CD95/Apo-1)/Fas ligand expression in neonates with pontosubicular neuron necrosis

Pediatric Research

Volumn 51, Issue 2, 2002, Pages 129-135

  Van Landeghem, Frank K H ^a   Felderhoff Mueser, Ursula ^a   Moysich, Axel ^a   Stadelmann, Christine ^a   Obladen, Michael ^a   Brück, Wolfgang ^a   Bührer, Christoph ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; FAS ANTIGEN; FAS LIGAND; GLIAL FIBRILLARY ACIDIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CLINICAL ARTICLE; CROSS LINKING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL NECROSIS; NEWBORN; NICK END LABELING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036154615     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200202000-00003     Document Type: Article

References (40)

1. Ponto-subicular lesions in perinatal anoxia
2. Evidence for neuronal apoptosis in pontosubicular neuron necrosis
3. Cell injury and death
4. Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia-ischaemia
5. Nuclear condensation and fragmentation following cerebral hypoxia-ischemia occurs more frequently in immature than older rats
6. Poly(ADP ribose) polymerase cleavage precedes neuronal death in the hippocampus and cerebellum following injury to the developing rat forebrain
7. Apoptosis in the brains of infants suffering intrauterine cerebral injury
8. Progressive expression of immunomolecules on activated microglia and invading leucocytes following focal cerebral ischemia in the rat
9. Cytokines and perinatal brain injury
10. Brain tissue responses to ischemia
11. The Fas death factor
12. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
13. Fas antigen signals proliferation of normal human diploid fibroblasts and its mechanism is different from tumor necrosis factor receptor
14. Fas ligand-induced apoptosis as a mechanism of immune privilege
15. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
16. Unraveling the immune privilege
17. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
18. Fas/Apo [apoptosis]-I and associated proteins in the differentiating cerebral cortex: Induction of caspase-dependent cell death and activation of NF-kappaB
19. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system
20. Fas antigen expression in brains of patients with Alzheimer-type dementia
21. Involvement of the CD95 (APO-I/Fas) receptor/ligand system in the multiple sclerosis brain
22. CD95 ligand (Fas-L/APO-IL) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
23. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxicischemic injury to the developing rat brain
24. High temperature retrieval and loss of nuclear morphology: A comparison of microwave and autoclave techniques
25. Differentiation between cellular apoptosis and necrosis by combined use of TUNEL and nick translation techniques
26. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
27. Localisation of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridisation
28. Clinicopathological study of pontosubicular necrosis
29. Clinicopathological study of germinal matrix hemorrhage, pontosubicular necrosis, and periventricular leukomalacia in stillborn
30. Functional change of NMDA receptors related to enhancement of susceptibility to neurotoxicity in the developing pontine nucleus
31. Expression of cell death-associated proteins in neuronal apoptosis associated with pontosubicular necrosis
32. Transient expression of apolipoprotein-E in neonates with pontosubicular neuron necrosis
33. Cu,Zn-superoxide dismutase reaction in neonatal pontosubicular neuron necrosis
34. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
35. Fas system up-regulation in experimental autoimmune encephalomyelitis
36. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier
37. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity
38. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
39. Neuroprotection by a caspase inhibitor in acute bacterial meningitis
40. From bench to clinic with apoptosis-based therapeutic agents